Search Results 1-10 of 16220 for what is vedolizumab

  1. Vedolizumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody ...

  2. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Your doctor will likely diagnose Crohn's disease only after ruling out other possible causes for your signs and symptoms. There is no single test to ...

  3. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), ...

  4. Ulcerative colitis - Diagnosis and treatment - Mayo Clinic

    Other types of tests can help rule out complications or other forms of inflammatory bowel disease, such as Crohn's disease. To help confirm a diagnosis of ...

  5. Crohn's disease - Symptoms and causes - Mayo Clinic

    Crohn's disease is a type of inflammatory bowel disease (IBD). It causes swelling of the tissues (inflammation) in your digestive tract, which can lead to ...

  6. Ulcerative colitis - Symptoms and causes - Mayo Clinic

    Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in your digestive tract.

  7. Vedolizumab (Intravenous Route, Subcutaneous Route) Precautions - Mayo Clinic

    Your vaccinations need to be current before you receive vedolizumab. Do not take other medicines unless they have been discussed with your doctor. This includes ...

  8. Vedolizumab (Intravenous Route, Subcutaneous Route) Proper Use - Mayo Clinic

    For injection dosage form (prefilled pen or prefilled syringe):. For Crohn's disease and ulcerative colitis: Adults—The first 2 doses are given by a doctor ...

  9. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  10. Vedolizumab (Intravenous Route, Subcutaneous Route) Side Effects - Mayo Clinic

    Incidence not known · Bloating · blurred vision · chest pain · clay-colored stools · confusion · constipation · dark urine · drowsiness ...